A Study To Investigate Whether PF-04457845 Is Effective In Treating Pain, Is Safe And Tolerable In Patients With Osteoarthritis Of The Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Osteoarthritis, Knee
Interventions
DRUG

PF-04457845

PF-04457845 4 mg tablet once daily / matched placebo

DRUG

PF-04457845

PF-04457845 4 mg tablet once daily / matched placebo

DRUG

Naproxen

Naproxen 500 mg tablet twice daily / matched placebo

DRUG

Naproxen

Naproxen 500 mg tablet twice daily / matched placebo

Trial Locations (7)

33143

Arthritis & Rheumatic Care Center, Miami

Miami Research Associates, Miami

66211

Vince and Associates Clinical Research, Overland Park

66212

Vince and Associates Clinical Research, Overland Park

78217

CEDRA Clinical Research, LLC, San Antonio

J1H 1Z1

Diex Research Inc., Sherbrooke

405 30

Centrum for klinisk provning, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY